Product Details
Safacto AF Injection 500IU Price In Pakistan
Safacto AF Injection 500IU contains recombinant Coagulation Factor VIII and is used as factor-replacement therapy for patients with Hemophilia A (Factor VIII deficiency). It works by replacing the deficient clotting factor, helping the blood form clots and supporting the control or prevention of bleeding episodes.
Safacto AF is supplied as a lyophilized powder that is prepared before intravenous administration. It should be used only under the supervision of a hematologist or healthcare professional experienced in treating Hemophilia A.
Benefits
- Contains Recombinant Coagulation Factor VIII 500 IU
- Used for Factor VIII replacement in Hemophilia A
- Helps control bleeding episodes
- May be used for prevention of bleeding when prescribed for prophylaxis
- Can be used as part of specialist-directed treatment around surgical procedures
Specifications
| Specification | Details |
|---|---|
| Brand | Safacto AF |
| Active Ingredient | Recombinant Coagulation Factor VIII |
| Strength | 500 IU |
| Dosage Form | Lyophilized Powder for Injection |
| Administration | Intravenous (IV) |
| Medicine Type | Prescription Factor Replacement |
| Main Use | Hemophilia A / Factor VIII Deficiency |
| Manufacturer | Saman Daroo 8 |
| Country of Manufacturer | Iran |
| Pack | 1 vial, according to listed product information |
How to Use
- Safacto AF should be used only according to the treatment plan prescribed by your hematologist.
- The powder must be reconstituted with the supplied diluent according to the manufacturer's instructions.
- The prepared medicine is administered intravenously by an appropriately trained healthcare professional.
- The required dose depends on factors such as body weight, severity and location of bleeding, Factor VIII level, and the patient's clinical response.
- Do not change the dose or treatment schedule without medical advice.
Why Choose Safacto AF 500IU?
- Contains recombinant Factor VIII
- Provides targeted factor-replacement therapy for Factor VIII deficiency
- Available in a 500 IU vial
- Manufactured by Saman Daroo 8
- Designed for specialist-managed treatment and prevention of bleeding associated with Hemophilia A
